Skip to content

First-in-human study of OT-A201 in patients with selected hematological malignancies and solid tumors

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-511936-28-00
Acronym
A20101
Enrollment
239
Registered
2024-06-14
Start date
2023-05-12
Completion date
Unknown
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed/refractory hematological malignancies or advanced/metastatic solid tumors

Interventions

None listed

Sponsors

Onward Therapeutics France
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026